Autopsy report · NCT00997477
Correct Use of Sequential Formoterol and Budesonide Inhaler Capsule Treatment Via Aerolizer and Patient Satisfaction in Asthmatics
Cause of deathNo reason given
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 4
- Sponsor
- Novartis Pharmaceuticals
- Sponsor type
- Industry
- Conditions
- Asthma
- Interventions
- Foradil Combi (Formoterol-budesonide)
- Participants
- 0
- Sites
- 4
- Countries
- Turkey (Türkiye)
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.